HKSE - Delayed Quote HKD

InnoCare Pharma Limited (9969.HK)

Compare
6.150 -0.020 (-0.32%)
At close: 4:08:20 PM GMT+8

Environment, Social and Governance (ESG) Risk Ratings

Total ESG Risk Score

30.4

Severe

ESG Risk Score for Peers

NameTotal ESG Risk scoreESG
AVTE Aerovate Therapeutics, Inc. 30 -- -- --
AVDL Avadel Pharmaceuticals plc 30 -- -- --
9969.HK INNOCARE 30 -- -- --
0L35.L SAREPTA THERAPEUTICS INC SAREPT 30 2 21 7
UR8.SG UroGen Pharma Ltd. 30 -- -- --

Controversy Level

ESG data provided by Sustainalytics, Inc. Last Updated on 12/2024
9969.HK
Category Average
N/A None Controversy Level
None 4 Severe

Product Involvement Areas

Products and Activities Significant Involvement
Alcoholic Beverages No
Adult Entertainment No
Gambling No
Tobacco Products No
Animal Testing Yes
Fur and Specialty Leather No
Controversial Weapons No
Small Arms No
Catholic Values No
GMO No
Military Contracting No
Pesticides No
Thermal Coal No
Palm Oil No

Related Tickers